Neumora Therapeutics, Inc. (NMRA)
NASDAQ: NMRA · Real-Time Price · USD
15.51
+0.11 (0.71%)
At close: Oct 11, 2024, 4:00 PM
15.50
-0.01 (-0.06%)
After-hours: Oct 11, 2024, 4:43 PM EDT
Neumora Therapeutics Market Cap
Neumora Therapeutics has a market cap or net worth of $2.48 billion as of October 11, 2024. Its market cap has increased by 23.56% in one year.
Market Cap
2.48B
Enterprise Value
2.11B
1-Year Change
23.56%
Ranking
Category
Stock Price
$15.51
Market Cap Chart
Since the IPO on September 15, 2023, Neumora Therapeutics's market cap has decreased from $2.58B to $2.48B, a decrease of -3.91%. That is a compound annual growth rate of -3.65%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Oct 11, 2024 | 2.48B | -4.67% |
| Dec 29, 2023 | 2.60B | 0.79% |
View and export this data all the way back to 2023.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| BrightSpring Health Services | 2.60B |
| Janux Therapeutics | 2.58B |
| Concentra Group Holdings Parent | 2.54B |
| ImmunityBio | 2.54B |
| Zai Lab | 2.49B |
| ACADIA Pharmaceuticals | 2.47B |
| Inari Medical | 2.44B |
| Tandem Diabetes Care | 2.43B |